Insmed (INSM) PT Raised to $40 at BofA Securities
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $103.38 -1.04%
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
BofA Securities analyst Jason Zemansky raised the price target on Insmed (NASDAQ: INSM) to $40.00 (from $37.00) while maintaining a Buy rating.
You May Also Be Interested In
- Acuity Brands (AYI) PT Raised to $465 at Oppenheimer
- Northrop Grumman (NOC) PT Lowered to $580 at Jefferies
- Incyte (INCY) PT Raised to $113 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
